Hydroxyprogesterone Caproate Injection
Product Images NDC 55150-311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydroxyprogesterone Caproate (NDC 55150-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (1,250 mg per 5 mL (250 mg / mL))

Package Label-principal Display Panel (1,250 mg per 5 mL (250 mg / mL))
This is a medication called Hydroxyprogesterone, contained in a sterile vial with NDC code 55150-311-01. Information about dosage and administration can be found in the insert. It should be stored at controlled room temperature between 20°to 25°C (68° to 77°F) and is manufactured by AuroMedics Pharma LLC in New Jersey. The vial is 5 mL in size and designated for intramuscular use.*
FDA Label Image

Package Label-principal Display Panel (1,250 mg per 5 mL (250 mg / mL) – Container-Carton (1 vial))

Package Label-principal Display Panel (1,250 mg per 5 mL (250 mg / mL) – Container-Carton (1 vial))
This is a description of Hydroxyprogesterone Caproate Injection, USP, manufactured by Auromedics. The 5 mL Multiple Dose Vial contains 250 mg hydroxyprogesterone caproate USP in castor oil and other preservatives. The dosage and administration instructions are provided in the insert. The vial stopper does not contain natural rubber latex. It is for intramuscular use only and should be stored at controlled room temperature. The product is distributed by Auromedics Pharma LLC in New Jersey, USA.*
FDA Label Image

Package Label-principal Display Panel (1,250 mg per 5 mL (250 mg / mL) – Container-Carton (5 vials))

Package Label-principal Display Panel (1,250 mg per 5 mL (250 mg / mL) – Container-Carton (5 vials))
Hydroxyprogesterone Caproate Injection, USP is a prescription medicine that contains 250 mg hydroxyprogesterone caproate USP in castor oil and 46% benzyl berzaate (v) with 2% benzy alconol (u/) as a preservative. It is provided in 1,250 mg per 5 mL (250 mg / mL) strength for intramuscular use only. The medicine comes in 5 x 5 mL multiple dose vials, and each vial states manufacturer AP AUROMEDICS, along with the address for distribution by AuwoMedics Pharma LLC. Dosage and Administration must be consulted before using this medicine. This medicine should be stored at 20° to 25°C (68° to 77°F) as controlled room temperature. The V stopper is not made with natural rubber latex.*
FDA Label Image

Chemical Structure (Hydroxyprogesterone Str)

Chemical Structure (Hydroxyprogesterone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.